BSX - Boston Scientific Corporation
NEXT EARNINGS:
Apr 22, 2026
EPS Est: $0.80
|
Rev Est: $5.2B
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$108.35
DETAILS
HIGH:
$130.00
LOW:
$94.00
MEDIAN:
$110.00
CONSENSUS:
$108.35
UPSIDE:
55.94%
Market Cap:
103.10B
Volume:
9,758,429
Avg Volume:
14,257,967
52 Week Range:
67.56-109.5
Sector:
Healthcare
Industry:
Medical - Devices
Beta:
0.70
Last Dividend:
$N/A
Exchange:
NYSE
Country:
US
Employees:
53,000
IPO Date:
1992-05-19
EPS (TTM):
1.96
P/E Ratio:
48.91
Revenue (TTM):
20.07B
Total Assets:
43.67B
Total Debt:
12.42B
Cash & Equiv:
2.04B
Rev Growth (5Y):
15.2%
EPS Growth (5Y):
25.2%
FCF Growth (5Y):
26.4%
ROCE:
9.8%
Debt/Equity:
0.51
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-02-04 | $0.80 | $0.78 | +2.4% | $5.3B | $5.3B | +0.1% |
| 2025-10-22 | $0.75 | $0.71 | +5.0% | $5.1B | $5.0B | +1.9% |
| 2025-07-23 | $0.75 | $0.72 | +3.4% | $5.1B | $4.9B | +3.4% |
| 2025-04-23 | $0.75 | $0.67 | +11.4% | $4.7B | $4.6B | +2.0% |
| 2025-02-05 | $0.70 | $0.66 | +6.5% | $4.6B | $4.4B | +3.2% |
| 2024-10-23 | $0.63 | $0.59 | +7.1% | $4.2B | $4.0B | +4.2% |
| 2024-07-24 | $0.62 | $0.58 | +6.3% | $4.1B | $4.0B | +2.3% |
| 2024-04-24 | $0.56 | $0.51 | +8.9% | $3.9B | $3.7B | +4.7% |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 20.07B | 16.75B | 14.24B | 12.68B | 11.89B | 9.91B | 10.73B | 9.82B | 9.05B | 8.39B | 7.48B | 7.38B |
| Net Income | 2.89B | 1.85B | 1.59B | 698.00M | 1.04B | (82.00M) | 4.70B | 1.67B | 104.00M | 347.00M | (239.00M) | (119.00M) |
| EPS | 1.96 | 1.26 | 1.08 | 0.45 | 0.69 | -0.08 | 3.38 | 1.21 | 0.08 | 0.26 | -0.18 | -0.09 |
| Total Assets | 43.67B | 39.40B | 35.14B | 32.47B | 32.23B | 30.78B | 30.57B | 21.00B | 19.04B | 18.10B | 18.13B | 16.83B |
| Total Debt | 12.42B | 11.15B | 9.49B | 9.28B | 9.45B | 9.54B | 10.28B | 7.03B | 5.58B | 5.48B | 5.68B | 4.26B |
| Cash & Equivalents | 2.04B | 414.00M | 865.00M | 928.00M | 1.93B | 1.73B | 217.00M | 146.00M | 188.00M | 196.00M | 319.00M | 587.00M |
| Operating Cash Flow | 4.53B | 3.44B | 2.50B | 1.53B | 1.87B | 1.51B | 1.84B | 310.00M | 1.43B | 972.00M | 600.00M | 1.27B |
| Free Cash Flow | 3.66B | 2.65B | 1.70B | 914.00M | 1.32B | 1.13B | 1.38B | (6.00M) | 1.11B | 596.00M | 353.00M | 1.01B |
| FCF per Share | 2.47 | 1.80 | 1.17 | 0.64 | 0.93 | 0.80 | 0.99 | -0.00 | 0.81 | 0.44 | 0.27 | 0.76 |
| Book Value | 24.23B | 21.77B | 19.28B | 17.57B | 16.62B | 15.33B | 13.88B | 8.72B | 7.01B | 6.73B | 6.32B | 6.84B |
| Cash & ST Investments | 2.04B | 414.00M | 865.00M | 928.00M | 1.93B | 1.73B | 217.00M | 146.00M | 188.00M | 196.00M | 319.00M | 587.00M |
| ROC Equity | 0.12 | 0.09 | 0.08 | 0.04 | 0.06 | -0.01 | 0.34 | 0.19 | 0.01 | 0.05 | -0.04 | -0.02 |